Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Hametum Wund- und Heilsalbe is a topical herbal medicinal ointment containing Hamamelis virginiana distillate as its active ingredient. Developed by Dr. Willmar Schwabe GmbH & Co. KG, it is primarily used for the treatment of minor skin injuries, abrasions, and localized inflammations of the skin and mucous membranes. The therapeutic effect is attributed to tannins within the distillate, which form a protective protein layer on the skin, providing anti-inflammatory, anti-pruritic (itch-reducing), and mild hemostatic (bleeding-stopping) properties. It has also been evaluated in Phase IV clinical trials for managing drug-induced skin disorders, such as dryness and fissures caused by systemic medications.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on hamamelis virginiana distillate.